Biomedical innovation - driver of common good or exacerbator of health inequality?

15 Jun 2022
In conversation with
Supporter session , In conversation with

In 2020 Sir Michael Marmot published a new report focused on recovery post pandemic and tackling health inequalities. The report shows the significant focus needed and investment to level-up the UK and halt widening gap in life expectancy and ill health.

In July 2021 the Government launched its 10-year strategy for the Life Science sector to solve some of the biggest healthcare problems of our generation, including cancer and dementia. In April the ABPI published a report demonstrating the potential value of biomedical innovation to health and wealth in the UK.

This session will engage with leaders from NHS England, ICS’s, industry and patient groups to explore their perspectives on the importance of innovation and its potential to become part of the solution to tackling health inequalities, rebuilding and recovery.

The panel will be facilitated again this year by Victoria Macdonald, the health and social care editor at Channel 4 News.

This session is supported by the Association of the British Pharmaceutical Industry (ABPI).

Victoria Macdonald, Health and Social Care Editor - Channel 4 News
Blake Dark, Commercial Medicines Director - NHS England and NHS Improvement
Penny Dash, Chair - NW London Integrated Care System
Richard Erwin, GM - Roche
Sarah Woolnough, Chief Executive Officer - Asthma and Lung UK